Background: Extracellular vesicles (EVs) are submicron membrane-bound vesicles released
from various cells, which are emerging as a potential novel biomarker in cardiovascular …

The mechanisms contributing to an increased risk of thrombosis in uremia are complex and
require clarification. There is scant morphological evidence of membrane-dependent …

Background: The aim of this study was to discuss the possibility of mean platelet volume
(MPV) being a new risk factor in the etiology of portal venous thrombosis (PVT). Methods …

The methods you use for blood collection and processing will impact on the EVs that end up
in your isolated sample. Here we discuss the evidence to help you make the right decisions …

The prothrombotic fibrin clot phenotype has been reported in patients with thrombotic
antiphospholipid syndrome (APS) and venous thromboembolism (VTE). Protein composition …

INTRODUCTION: Elevated lipoprotein (a)(Lp (a)) has been established as a risk factor of
coronary heart disease and stroke. Findings concerning the risk of venous …

Venous thromboembolism (VTE) is a multifactorial disease, and pulmonary hypertension
(PH) is a serious condition characterized by pulmonary vascular remodeling leading with …

We conducted a study to assess the effect of rosuvastatin use on fibrinolysis in patients with
previous venous thromboembolism (VTE). This was a post hoc analysis within the STAtins …

Cell-derived microvesicles and nanovesicles (MVs) are present within body fluids (eg
plasma) and contribute to normal physiology (eg hemostasis) and pathology (eg …